| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/01/2009 | US20090004174 Fusion Proteins |
| 01/01/2009 | US20090004165 Feline probiotic Lactobacilli |
| 01/01/2009 | US20090004156 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE |
| 01/01/2009 | US20090004154 Method for treating a mammal having damaged pancreatic tissue |
| 01/01/2009 | US20090004148 Novel Probiotic |
| 01/01/2009 | US20090004147 Composition for a healthy gastrointestinal tract |
| 12/31/2008 | WO2009002935A1 Transdermal delivery system comprising glycopyrrolate to treat sialorrhea |
| 12/31/2008 | WO2009001938A1 Hydrophilic composition containing hinokitiol |
| 12/31/2008 | WO2009001937A1 Hydrophilic composition containing hinokitiol |
| 12/31/2008 | WO2009001915A1 Substituted imidazole compound and use thereof |
| 12/31/2008 | WO2009000558A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives |
| 12/31/2008 | WO2009000296A2 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 12/31/2008 | WO2009000149A1 Use of notoginsenoside r1 in the preparation of the medicament for treating hepatic injuries |
| 12/31/2008 | WO2009000146A1 Succinic acid-(5-androsten-17-one-3beta-ol)-diester solid dispersion, method for the production and the use thereof |
| 12/31/2008 | WO2009000132A1 Immediate release effervescent-formulation and preparing process thereof |
| 12/31/2008 | WO2009000085A1 Quinoline and quinazoline derivatives useful as modulators of gated ion channels |
| 12/31/2008 | WO2008121877A3 Cftr inhibitor compounds and uses thereof |
| 12/31/2008 | WO2008121386A3 Calcimimetic compounds for use in the treatment of bowel disorders |
| 12/31/2008 | WO2008120070A3 2(hydroxyethyl)trimethylammonium thioctate (choline thioctate) displaying hepatoprotective, hypoammoniemic and detoxic action, a method for its production and a pharmaceutical composition based thereon |
| 12/31/2008 | EP2009443A1 Diagnostic agent and therapeutic agent for pancreatic cancer |
| 12/31/2008 | EP2009024A1 Glucagon-like peptide-2 analogs |
| 12/31/2008 | EP2008658A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives |
| 12/31/2008 | EP2008654A1 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amides |
| 12/31/2008 | EP2008649A1 Spill resistant pharmaceutical compositions |
| 12/31/2008 | EP2008529A1 Enzyme-containing candy |
| 12/31/2008 | EP2007371A1 Lactate and calcium containing pharmaceutical composition and uses thereof |
| 12/31/2008 | EP2007365A2 Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith |
| 12/31/2008 | EP2007348A1 Paediatric amino acid solution for parenteral nutrition |
| 12/31/2008 | EP2007227A2 Lycopene for the treatment of metabolic dysfunction |
| 12/31/2008 | EP1896489B1 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof |
| 12/31/2008 | EP1765809B1 Xanthine derivatives useful as muscarinic receptor antagonists |
| 12/31/2008 | EP1546099B1 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists |
| 12/31/2008 | EP1436264B1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 12/31/2008 | EP1409483B1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 12/31/2008 | EP1341512B1 Rhinological agents |
| 12/31/2008 | EP1312667B1 Probiotic products containing L. salivarius strain |
| 12/31/2008 | EP1192125B1 Mono-substituted 3-propyl gamma-aminobutyric acids |
| 12/31/2008 | EP0759937B2 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 12/31/2008 | CN101336238A Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides |
| 12/31/2008 | CN101333259A Preparation of <99m>Tc galactosyl human serum albumin fusion interferon of liver receptor developer and uses thereof |
| 12/31/2008 | CN101333256A Human antibodies that bind human il-12 and methods for producing |
| 12/31/2008 | CN101332295A Enteric-coated glucosinolates and beta-thioglucosidases |
| 12/31/2008 | CN101332289A Health product for facilitating alcohol metabolism and protecting liver and preparation method thereof |
| 12/31/2008 | CN101332287A Quality control method of Danle capsule |
| 12/31/2008 | CN101332285A Traditional Chinese medicine formula for treating gastropathy |
| 12/31/2008 | CN101332284A Chinese traditional medicine composition for treating ulcerative colitis and its preparation method |
| 12/31/2008 | CN101332273A Dietotherapy double-purpose traditional Chinese medicine composition for elderly people |
| 12/31/2008 | CN101332272A Traditional Chinese medicine formula for treating gastropathy |
| 12/31/2008 | CN101332266A Medicinal wine of sixteen ingredients with Rehmannia |
| 12/31/2008 | CN101332250A Traditional Chinese medicine for repairing gastric mucosa |
| 12/31/2008 | CN101332248A Medicine for treating hepatic fibrosis |
| 12/31/2008 | CN101332235A Magnolia bark and processing technique |
| 12/31/2008 | CN101332225A Traditional Chinese medicine composition for treating chronic atrophic gastritis |
| 12/31/2008 | CN101332209A Compound amino acid injection for treating hepatic encephalopathy |
| 12/31/2008 | CN101332203A Medicine for preventing and curing porcine diarrhea |
| 12/31/2008 | CN101332197A Loperamide hydrochloride dimethicone compound rapidly disintegrating oral membrane |
| 12/31/2008 | CN101331947A Cookies formula with catharsis effect and preparation method thereof |
| 12/31/2008 | CN101331924A Method for producing inulin syrupy using waste fluid of producing inulin |
| 12/31/2008 | CN101331908A Brown sugar candy and production method thereof |
| 12/31/2008 | CN100447243C HBV specificity interference target point gene and its siRNA and application in anti HBV infecting thereof |
| 12/31/2008 | CN100447160C Modified acacia and use thereof |
| 12/31/2008 | CN100447154C Use of HMG fragments as anti-inflammatory agents |
| 12/31/2008 | CN100447141C Hetero-bicyclic crf antagonists |
| 12/31/2008 | CN100447136C New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors |
| 12/31/2008 | CN100446813C Hepatitis A-hepatitis E combined vaccine and preparation method thereof |
| 12/31/2008 | CN100446798C Chinese herbal medicine decoction for treating B-type hepatitis and preparing method |
| 12/31/2008 | CN100446794C Chinese medicinal formulation for treating gastrointestinal disease |
| 12/31/2008 | CN100446793C Chinese-medicinal composition for treating enterogastric diseases |
| 12/31/2008 | CN100446787C Chinese medicinal compsns. for treating digestive ulcer and chronic gastritis, its prepn. and usage |
| 12/31/2008 | CN100446785C Peppermint oil dripping pills and its prepn. method |
| 12/31/2008 | CN100446784C Chinese medicine for colitis and its preparation process |
| 12/31/2008 | CN100446783C Method for preparing injection of astragalus |
| 12/31/2008 | CN100446781C Method for preparing general saponin of golden Chinese gentian and application |
| 12/31/2008 | CN100446777C Multifuntional health-care oral liquid |
| 12/31/2008 | CN100446768C Mosapride citrate capsule and preparation process thereof |
| 12/31/2008 | CN100446763C Oral microemulsion composition comprising biphenyldimethyldicarboxylate and silybin |
| 12/31/2008 | CN100446762C (-)-epigallocatechin gallate solid dispersion and its prepn and application |
| 12/31/2008 | CN100446756C Preparation of composite drug-loaded nanoparticles of carboxyl-chitosan and chitosan modified by glycyrrhizanates |
| 12/31/2008 | CA2691415A1 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 12/31/2008 | CA2689299A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives |
| 12/30/2008 | US7470710 Such as 2-Benzofuranylmethyl-1-((5-(4-fluorophenyl)-2-methyl-thiazolyl) carbonyl)piperidine; obesity, type 2 diabetes, sleep disorders; strokes, blocking emetic response |
| 12/30/2008 | US7470704 Benzonaphthyridines |
| 12/30/2008 | US7470687 Aryl oximes |
| 12/30/2008 | US7470686 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres |
| 12/30/2008 | US7470681 Pyrimidine compounds |
| 12/30/2008 | US7470437 Utilizing nanocrystalline silver metal, alloy or compound for mucosal, serosal, respiratory, circulatory and/or musculo-skeletal conditions |
| 12/30/2008 | CA2441771C Dihydro-benzo[b][1,4]diazepin-2-one derivatives as mglur2 antagonists i |
| 12/30/2008 | CA2412560C Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 12/30/2008 | CA2400237C Pluraflavins and derivatives thereof, process for their preparation and use thereof |
| 12/30/2008 | CA2391497C Use of 5ht3 agonists for relaxing the fundus |
| 12/30/2008 | CA2391293C .beta.2-adrenergic receptor agonists |
| 12/30/2008 | CA2368767C Protease resistant flint analogs |
| 12/30/2008 | CA2366920C Pet food product with coconut endosperm fibre |
| 12/30/2008 | CA2356300C 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 12/30/2008 | CA2355269C Materials and methods for making improved micelle compositions |
| 12/30/2008 | CA2353048C Pharmaceutical composition useful in the prevention or treatment of peptic ulcers |
| 12/30/2008 | CA2351703C Novel 4-dedimethylaminotetracycline derivatives |
| 12/30/2008 | CA2312098C A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 12/30/2008 | CA2304958C Bioadhesive compositions and methods for topical administration of active agents |
| 12/30/2008 | CA2299423C Taste-masked pharmaceutical composition |